rethinkTHC Search
Menu
Study breakdown

CBD and THC relieve pain through different receptor systems in worm models

Animal StudyPreliminary evidence
The takeaway

In C. elegans, CBD reduced pain responses through vanilloid receptors while THC acted through cannabinoid receptors, and CBD effects reversed within 6 hours while THC effects persisted.

People interested in the science behind how cannabis compounds work for pain relief.

CBD effects reversed at 6 hours; THC effects did not

What the researchers found

CBD and THC both reduced the nocifensive response to noxious heat in C. elegans, but mutant studies revealed they target different receptor systems: CBD acts on vanilloid receptors (OSM-9/OCR-2) while THC targets cannabinoid receptors (NPR-19/NPR-32).

Why it matters

Understanding that CBD and THC relieve pain through entirely separate receptor pathways could inform the development of more targeted pain treatments and help explain why the two compounds produce different side effect profiles.

The numbers in context

CBD effects reversed 6 hours post-exposure. THC effects did not reverse in the same timeframe. Noxious heat range tested was 32-35 degrees C.

How the study worked

Researchers exposed C. elegans nematodes to CBD and THC, then measured thermal avoidance behavior. Specific receptor mutants were used to identify which receptor systems each compound targets. Proteomic analysis mapped activated metabolic pathways.

What this study cannot tell us

C. elegans is an extremely simple organism. While it expresses mammalian ortholog receptors, findings in worms do not directly translate to human pain biology. The thermal avoidance assay captures only one dimension of pain.

How to read the evidence

This is a preliminary animal model study using C. elegans nematodes. While the organisms express receptor orthologs similar to mammals, these findings are far from direct human evidence.

When this study was published

Published in 2024 using established C. elegans nociception methods.

The bigger picture

The opioid crisis has driven interest in cannabis-based pain alternatives. Pinpointing the distinct molecular targets of CBD versus THC in pain pathways is a step toward developing cannabinoid-based analgesics with fewer unwanted effects.

Questions still open

  • Do these distinct receptor pathways hold true in mammalian pain models? Could combining CBD and THC produce additive pain relief by hitting both systems simultaneously? Why does CBD pain relief reverse while THC pain relief persists?

Common questions

Why use worms to study pain?
C. elegans nematodes express receptor proteins similar to mammalian cannabinoid and vanilloid receptors, making them a useful early-stage model for identifying which molecular pathways CBD and THC engage.
What does it mean that CBD and THC target different receptors?
CBD appeared to work through vanilloid receptors (related to capsaicin/heat sensation) while THC worked through cannabinoid receptors. This suggests the two compounds reduce pain through fundamentally different biological mechanisms.

Read the original research

Cannabidiol and Tetrahydrocannabinol Antinociceptive Activity is Mediated by Distinct Receptors in Caenorhabditis elegans.

Neurochemical research, 49(4), 935-948

Citation

Boujenoui, Fatma; Nkambeu, Bruno; Salem, Jennifer Ben; Castano Uruena, Jesus David; Beaudry, Francis. (2024). Cannabidiol and Tetrahydrocannabinol Antinociceptive Activity is Mediated by Distinct Receptors in Caenorhabditis elegans.. Neurochemical research, 49(4), 935-948. https://doi.org/10.1007/s11064-023-04069-6

Explore the wider topic